Halogen‐Dependent Regulation of the Thyroid Hormone Transporter by Antipsychotic Drugs and Their Analogues

Antipsychotic drugs are primarily used to manage psychosis and other psychotic disorders. Their main mechanism of action involves blocking dopamine D2 receptors in the brain, and they remain important for the treatment for schizophrenia. In this paper, we describe an unusual property of several commonly used antipsychotic drugs and their analogues for their ability to modulate the thyroid hormone transporter system. Specifically, these compounds significantly increase the protein expression of monocarboxylate transporter 8 (MCT8), a key transporter responsible for carrying thyroid hormones across the plasma membrane in a variety of cell lines. Our findings indicate that the presence of halogen substituents plays a critical role in promoting the MCT8 upregulation. Furthermore, the magnitude of this effect is dependent on the nature of the halogen atom, with iodine-containing phenothiazine derivatives exhibiting the strongest induction of MCT8 expression. The increased transporter expression was accompanied by enhanced cellular uptake of MCT8-selective fluorescent probes, confirming functional activity. To the best of our knowledge, this study provides the first example of halogen-dependent regulation of protein expression in mammalian cells.

Authors

Institutions

Publication Details

Journal
Angewandte Chemie International Edition
Published
2026-11-18
DOI
https://doi.org/10.1002/anie.2824884
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Halogen‐Dependent Regulation of the Thyroid Hormone Transporter by Antipsychotic Drugs and Their Analogues

Govindasamy Mugesh, Debasish Giri, Ekta Chauhan, Sagar Kumar
Angewandte Chemie International Edition
Thyroid Disorders and Treatments
article

Halogen‐Dependent Regulation of the Thyroid Hormone Transporter by Antipsychotic Drugs and Their Analogues

Govindasamy Mugesh, Debasish Giri, Ekta Chauhan, Sagar Kumar
article en

Abstract

Antipsychotic drugs are primarily used to manage psychosis and other psychotic disorders. Their main mechanism of action involves blocking dopamine D2 receptors in the brain, and they remain important for the treatment for schizophrenia. In this paper, we describe an unusual property of several commonly used antipsychotic drugs and their analogues for their ability to modulate the thyroid hormone transporter system. Specifically, these compounds significantly increase the protein expression of monocarboxylate transporter 8 (MCT8), a key transporter responsible for carrying thyroid hormones across the plasma membrane in a variety of cell lines. Our findings indicate that the presence of halogen substituents plays a critical role in promoting the MCT8 upregulation. Furthermore, the magnitude of this effect is dependent on the nature of the halogen atom, with iodine-containing phenothiazine derivatives exhibiting the strongest induction of MCT8 expression. The increased transporter expression was accompanied by enhanced cellular uptake of MCT8-selective fluorescent probes, confirming functional activity. To the best of our knowledge, this study provides the first example of halogen-dependent regulation of protein expression in mammalian cells.

Angewandte Chemie International Edition
Indian Institute of Science Bangalore (IN)
Science and Engineering Research Board
Good health and well-being
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon